TY - JOUR
T1 - Colorectal cancer screening and surveillance
AU - Harford, William V.
PY - 2006/1/1
Y1 - 2006/1/1
N2 - Screening and surveillance substantially reduce both the incidence and mortality of colorectal cancer. Screening of normal-risk individuals may be accomplished by several methods, including fecal occult blood testing, fiberoptic sigmoidoscopy, double contrast barium enema, and colonoscopy. New technologies for screening are being developed, such as fecal immunochemical testing for blood, fecal DNA testing, and virtual colonoscopy. Patients at increased risk for colorectal cancer, such as those with a positive family history, previous adenomatous polyps or cancer, and inflammatory bowel disease, should be offered more intensive evaluation and surveillance.
AB - Screening and surveillance substantially reduce both the incidence and mortality of colorectal cancer. Screening of normal-risk individuals may be accomplished by several methods, including fecal occult blood testing, fiberoptic sigmoidoscopy, double contrast barium enema, and colonoscopy. New technologies for screening are being developed, such as fecal immunochemical testing for blood, fecal DNA testing, and virtual colonoscopy. Patients at increased risk for colorectal cancer, such as those with a positive family history, previous adenomatous polyps or cancer, and inflammatory bowel disease, should be offered more intensive evaluation and surveillance.
UR - http://www.scopus.com/inward/record.url?scp=29544447280&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=29544447280&partnerID=8YFLogxK
U2 - 10.1016/j.soc.2005.11.003
DO - 10.1016/j.soc.2005.11.003
M3 - Review article
C2 - 16389147
AN - SCOPUS:29544447280
SN - 1055-3207
VL - 15
SP - 1
EP - 20
JO - Surgical Oncology Clinics of North America
JF - Surgical Oncology Clinics of North America
IS - 1
ER -